Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the hypothesis that sympathetic neural outflow to muscles as well as a sympathetic baroreflexes are not altered during xenon anesthesia in Healthy Volunteers.


Clinical Trial Description

Objectives for this study :

- Main Objective : Influence of Xenon anesthesia on Sympathetic Nervous Activity

- Secondary Objectives : Security under LENOXeâ„¢ (xénon 100 % v/v) anesthesia ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01043419
Study type Interventional
Source Air Liquide Santé International
Contact
Status Completed
Phase Phase 1
Start date January 2010
Completion date March 2010

See also
  Status Clinical Trial Phase
Completed NCT03933787 - Neuropeptide Y and Sympathovagal Balance Early Phase 1
Completed NCT02972554 - Does Propranolol Attenuate Inflammatory Responses to a Psychological Stressor? Phase 4
Recruiting NCT04891432 - Comparison of Surgical Outcomes Between Pre Sympathetic Plexus and Post Sympathetic Plexus Approach
Enrolling by invitation NCT05971433 - Determining the Role of Sympathetic Activity in the Impact of Combat Injury on Sleep and Cardiovascular Outcomes
Withdrawn NCT02605551 - Hypertension and Osteopathic Treatment N/A